Efficacy of topical terbinafine 1% cream in the treatment of facial seborrhoeic dermatitis
Not Applicable
- Conditions
- Seborrhoeic dermatitis.Seborrhoeic dermatitis
- Registration Number
- IRCT138807202581N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Presence of seborrhoeic dermatitis
Exclusion criteria: application of any treatment that efficient in seborrhoeic dermatitis in last two weeks, presence of AIDS or Parkinson's disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of seborrehic dermatitis. Timepoint: baseline, 4th, 12th week. Method of measurement: Global score.
- Secondary Outcome Measures
Name Time Method Severity of pruritis. Timepoint: Baseline ,4th, 12th weeks. Method of measurement: severity of pruritus is graded from 0 to 3.;Severity of erythem. Timepoint: Baseline, 4th, 12th weeks. Method of measurement: severety of erythema is graded from 0 to 3.;Severety of scaling. Timepoint: baseline, 4th, 12th week. Method of measurement: severity of scaling is graded from 0 to 3.;Side effects. Timepoint: during treatment period. Method of measurement: Erythema or pruritus or burning or contact dermatitis.